Conversio Health Announces Leadership Transition and Appointment of Tom Frosheiser as CEO and Member of the Board of Directors
THE WOODLANDS, Texas, Jan. 16, 2019
THE WOODLANDS, Texas, Jan. 16, 2019 /PRNewswire-PRWeb/ -- Tom Frosheiser has joined Conversio Health as CEO and member of the company's board of directors. Mr. Frosheiser succeeds co-founder and former CEO, Kirk Clove who will remain on Conversio Health's board of directors and serve as a strategic advisor to the company.
Mr. Clove co-founded Conversio Health in 2013 to provide innovative solutions that improve the clinical, quality of life, and financial outcomes of those impacted by respiratory disease.
Mr. Frosheiser brings a respected track record of success in high-growth healthcare services, patient engagement and pharmacy businesses and will lead Conversio Health as it continues to address the challenges unique to living with and managing chronic health conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma.
Mr. Frosheiser previously served as CEO of Phytel (acquired by IBM), and General Manager & COO at Accordant Health Services (acquired by CVS/Caremark). He currently serves on the Board of Directors of Voi, Inc.
"Tom brings a wealth of experience in growing and operating high-growth healthcare companies as well as relevant industry knowledge in specialty pharmacy, disease management and patient engagement and we are excited to have Tom join our team."
– Jesse Bland, Principal of Heritage Group and member of Conversio Health's Board of Directors
About Conversio Health:
Conversio Health is a healthcare services and pharmacy provider with extensive experience in managing and treating chronic respiratory conditions. Conversio works collaboratively in the delivery of care, in accordance with agreed upon medication adherence protocols. Conversio Health is a licensed pharmacy that services patients in over 45 states, with nationwide distribution.
Conversio Health is Joint Commission accredited and a member of Professional Compounding Centers of America (PCCA), the International Academy of Compounding Pharmacists (IACP), the American Association of Diabetes Educators (AADE) and the American Association for Respiratory Care (AARC).
For further information on Conversio Health visit http://www.conversiohealth.com.
SOURCE Conversio Health